Structure of cholecystokinin receptor binding sites and mechanism of activation/inactivation by agonists/antagonists

被引:38
|
作者
Fourmy, D
Escrieut, C
Archer, E
Galès, C
Gigoux, V
Maigret, B
Moroder, L
Silvente-Poirot, S
Martinez, J
Fehrentz, JA
Pradayrol, L
机构
[1] CHU Rangueil, INSERM, U531, Louis Buhnard Inst, F-31403 Toulouse 4, France
[2] Univ Nancy, UHP, CNRS, UMR 7565, F-54506 Vandoeuvre Les Nancy, France
[3] Max Planck Inst Biochem, D-82143 Martinsried, Germany
[4] Fac Pharm Montpellier, CNRS, UMR 5810, F-34060 Montpellier, France
来源
PHARMACOLOGY & TOXICOLOGY | 2002年 / 91卷 / 06期
关键词
D O I
10.1034/j.1600-0773.2002.910608.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Delineation of CCK receptor binding sites is a prerequisite for the understanding of the molecular basis for ligand recognition, partial agonism. ligand-induced traffiking of receptor signalling. In the current paper, we illustrate how, in the past 5 years, studies from our laboratory and others have provided new data on the molecular basis of the pharmacology and functioning of CCK1 and CCK2 receptors. Available data on CCK1 and CCK2R binding sites indicate that 1) homologous regions of the two receptors are involved in the binding site of CCK, however, positioning of CCK slightly differs; 2) binding sites of non-peptide agonists/antagonist are buried in the pocket formed by transmembrane helices and overlap that of CCK and 3) residues of the binding sites as well as of conserved motifs such as E/DRY, NPXXY are crucial for receptor activation.
引用
收藏
页码:313 / 320
页数:8
相关论文
共 50 条
  • [1] LACK OF COMPETITION BETWEEN 2 REPUTED PERIPHERAL CHOLECYSTOKININ RECEPTOR ANTAGONISTS FOR CENTRAL CHOLECYSTOKININ BINDING-SITES
    CLARK, CR
    DAUM, P
    HUGHES, J
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1985, 448 (JUL) : 581 - 582
  • [2] Recent advances in the chemistry of cholecystokinin receptor ligands (agonists and antagonists)
    de Tullio, P
    Delarge, J
    Pirotte, B
    [J]. CURRENT MEDICINAL CHEMISTRY, 1999, 6 (06) : 433 - 455
  • [3] Exploring the Binding Mechanism of GABAB Receptor Agonists and Antagonists through in Silico Simulations
    Lima Neto, Jose X.
    Bezerra, Katyanna S.
    Barbosa, Emmanuel D.
    Oliveira, Jonas I. N.
    Manzoni, Vinicius
    Soares-Rachetti, Vanessa P.
    Albuquerque, Eudenilson L.
    Fulco, Umberto L.
    [J]. JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2020, 60 (02) : 1005 - 1018
  • [4] Are radioligand antagonist agonist binding ratios in rat pancreas predictive of functional efficacy of cholecystokinin receptor agonists and antagonists?
    Patel, S
    Chapman, KL
    Smith, AJ
    Bailey, I
    Freedman, SB
    [J]. REGULATORY PEPTIDES, 1996, 65 (01) : 29 - 35
  • [5] EQUILIBRIUM BINDING ANALYSIS OF ESTROGEN AGONISTS AND ANTAGONISTS - RELATION TO THE ACTIVATION OF THE ESTROGEN-RECEPTOR
    SASSON, S
    [J]. PATHOLOGIE BIOLOGIE, 1991, 39 (01): : 59 - 69
  • [6] Human pregnane X receptor antagonists and Agonists define molecular requirements for different binding sites
    Ekins, Sean
    Chang, Cheng
    Mani, Sridhar
    Krasowski, Matthew D.
    Reschly, Erica J.
    Iyer, Manisha
    Kholodovych, Vladyslav
    Ai, Ni
    Welsh, William J.
    Sinz, Michael
    Swaan, Peter W.
    Patel, Rachana
    Bachmann, Kenneth
    [J]. MOLECULAR PHARMACOLOGY, 2007, 72 (03) : 592 - 603
  • [7] Insights into the binding and activation sites of the receptors for cholecystokinin and gastrin
    Foucaud, Magall
    Archer-Lahlou, Elodie
    Marco, Esther
    Tikhonova, Irina G.
    Maigret, Bernard
    Escrieut, Chantal
    Langer, Ingrid
    Fourmy, Daniel
    [J]. REGULATORY PEPTIDES, 2008, 145 (1-3) : 17 - 23
  • [8] Affinity of cholecystokinin receptor antagonists for the gastrin-binding protein
    Rorison, KA
    Yang, ZY
    Baldwin, GS
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 388 (01) : 9 - 15
  • [9] Comparative receptor binding analyses of cannabinoid agonists and antagonists
    Thomas, BF
    Gilliam, AF
    Burch, DF
    Roche, MJ
    Seltzman, HH
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 285 (01): : 285 - 292
  • [10] Receptor binding analysis of cannabinoid agonists and antagonists.
    Thomas, BF
    Gilliam, AF
    Burch, DF
    Roche, MJ
    Seltzman, HH
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R49 - R49